InvestorLens

BMRN — BIOMARIN PHARMACEUTICAL INC

Health Care

Sign in to save5 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying BMRN?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Net accumulation · 6 buying vs 0 selling last quarter
74
Macro Tailwind
Macro conditions are mixed for this sector
53
Why? — Evidence & Confidence ▾

Of 6 tracked investors who changed their BMRN position last quarter, 6 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime).

Supporting evidence
  • +6 tracked investors added or increased positions last quarter (Izzy Englander, Ken Griffin, Paul Tudor Jones, …)
  • +5 tracked investors reported holding BMRN at their latest filing
Contradicting evidence — always shown
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About BIOMARIN PHARMACEUTICAL INC (BMRN)

BIOMARIN PHARMACEUTICAL INC (BMRN) appears in the most recent 13F filings of 5 tracked institutional investors. BIOMARIN PHARMACEUTICAL INC is classified in the Health Care sector. The largest disclosed position is held by Andreas Halvorsen (Viking Global Investors), valued at $763M. Across recent filings, tracked investors recorded 12 new positions, 23 increased, 10 reduced, and 5 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in BMRN

70
/100
Institutional Accumulation
Added / Increased35
Reduced10
Exited5
BearishBullish
Crowded Trade Score™

How many top investors track BMRN

33
/100
Emerging Interest
5investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

BMRN Ownership Composition

How BIOMARIN PHARMACEUTICAL INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
61% of tracked value
Institutions
5
tracked investors
Total Reported
$715.2M
combined 13F value
Types4
  • Other60.9%
  • Multi-Strategy / Quant28.1%
  • Value & Distressed8.7%
  • Macro2.2%
Other(1)
60.9%
Multi-Strategy / Quant(2)
28.1%
Value & Distressed(1)
8.7%
Macro(1)
2.2%

Tracked investors currently reporting BMRN

2 tracked investors have since exited this position — listed separately below.

  • Andreas HalvorsenJun 30, 2026
    Viking Global Investors
    Shares
    7.6M
    Value
    $435.8M
    % Portfolio
    1.24%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    1.4M
    Value
    $80.3M
    % Portfolio
    0.01%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    2.1M
    Value
    $121M
    % Portfolio
    0.04%
  • Howard MarksJun 30, 2026
    Oaktree Capital Management
    Shares
    64M
    Value
    $62.4M
    % Portfolio
    0.87%
  • Ray DalioJun 30, 2026
    Bridgewater Associates
    Shares
    274.9K
    Value
    $15.7M
    % Portfolio
    0.06%

Previously held BMRN

These investors reported BMRN in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Steve CohenPoint72 Asset Management1.3M$73.4MMar 31, 2026
Paul Tudor JonesTudor Investment Corp162.2K$9.6MDec 31, 2025

Recent activity

Frequently asked questions

How many institutional investors hold BMRN?
5 tracked institutional investors disclosed a position in BMRN (BIOMARIN PHARMACEUTICAL INC) in their most recent 13F filing.
Who is the largest institutional holder of BMRN?
Andreas Halvorsen, Viking Global Investors, holds the largest disclosed position in BMRN, valued at $763M.
Did institutional ownership of BMRN increase or decrease?
Across recent 13F filings, tracked investors recorded 12 new positions, 23 increased, 10 reduced, and 5 fully exited BMRN.
What sector is BMRN in?
BIOMARIN PHARMACEUTICAL INC is classified in the Health Care GICS sector.
Where does this BMRN ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
BMRN (BIOMARIN PHARMACEUTICAL INC) — Institutional Holders — InvestorLens